Frequent Links
public administrationAccountingAutismAyurvedic Medicinesoftware-engineering-usesSkeletal dysplasia Peer-review JournalsHuman Papillomavirus-16Tissue engineeringAcademic Trials JournalsAncient diseases preventive remedies open access articlesLegal-Sciences-peer-review-journalsStock-Market-Review-ArticlesBiochemical medicine Top JournalsUse of Proteomics in Drug Designingpharmaceutical chemistry organic process research journals online
Lesogaberan
| 200px | ||
| colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other This page is a soft redirect. Names #REDIRECTmw:Help:Magic words#Other |
IUPAC name
((R)-3-Amino-2-fluoropropyl)phosphinic acid
| |
|---|---|---|
| Other names
AZD-3355
| ||
| colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other This page is a soft redirect. Identifiers#REDIRECTmw:Help:Magic words#Other This page is a soft redirect.-
|
344413-67-8 7px= 7px | |
| ChEMBL | ChEMBL448343 7px | |
| ChemSpider | 23254384 7px | |
| Jmol-3D images | Image | |
| PubChem | Template:Chembox PubChem/format | |
| colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other This page is a soft redirect. Properties #REDIRECTmw:Help:Magic words#Other |
C3H9FNO2P | |
| Molar mass | Lua error in Module:Math at line 495: attempt to index field 'ParserFunctions' (a nil value). g·mol−1 | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | ||
| 14px verify (what is: 10px/10px?) | ||
| Infobox references | ||
Lesogaberan (AZD-3355) was[1] an experimental drug candidate developed by AstraZeneca for the treatment of gastroesophageal reflux disease (GERD).[2] As a GABAB receptor agonist,[3] it has the same mechanism of action as baclofen, but is anticipated to have fewer of the central nervous system side effects that limit the clinical use of baclofen for the treatment of GERD.[4]
References
- ^ AstraZeneca. "AZD3355". Retrieved 30 December 2011.
- ^ Bredenoord, Albert J. (2009). "Lesogaberan, a GABAB agonist for the potential treatment of gastroesophageal reflux disease". IDrugs 12 (9): 576–584. PMID 19697277.
- ^ Alstermark; Amin, K; Dinn, SR; Elebring, T; Fjellström, O; Fitzpatrick, K; Geiss, WB; Gottfries, J et al. (2008). "Synthesis and Pharmacological Evaluation of Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonists as Gastroesophageal Reflux Inhibitors". Journal of Medicinal Chemistry 51 (14): 4315–4320. PMID 18578471. doi:10.1021/jm701425k.
- ^ Brian E. Lacy, Robert Chehade, and Michael D. Crowell (2010). "Lesogaberan". Drugs of the Future 35 (12): 987–992. doi:10.1358/dof.2010.035.012.1540661.
| ||||||||||||||||||||||||||||||||||||||||||||
Lua error in package.lua at line 80: module 'Module:Buffer' not found.